Straits Times Index
3,323.20 -6.89 (-0.21%) S&P 500
5,276.48 -29.56 (-0.56%) Dow
38,483.53 -369.33 (-0.95%) Nasdaq
16,966.79 -53.09 (-0.31%) Bitcoin USD
67,444.52 -311.40 (-0.46%) CMC Crypto 200
1,451.87 -32.82 (-2.21%)
RVNC Jun 2024 2.500 put
| Previous close | 0.1500 |
| Open | 0.1300 |
| Bid | 0.1000 |
| Ask | 0.2000 |
| Strike | 2.50 |
| Expiry date | 2024-06-21 |
| Day's range | 0.1300 - 0.1500 |
| Contract range | N/A |
| Volume | |
| Open interest | 160 |
- Business Wire
Revance to Participate in Upcoming Investor Conferences
NASHVILLE, Tenn., May 28, 2024--Revance to Participate in Upcoming Investor Conferences
ZacksRevance Therapeutics (RVNC) Loses -18.85% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Revance Therapeutics (RVNC) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Insider MonkeyRevance Therapeutics, Inc. (NASDAQ:RVNC) Q1 2024 Earnings Call Transcript
Revance Therapeutics, Inc. (NASDAQ:RVNC) Q1 2024 Earnings Call Transcript May 9, 2024 Revance Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the Revance Therapeutics First Quarter2024 Financial Results and Corporate Update Conference Call. At this time, […]
